Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. William Gradishar

Breast Oncology · NU

View

Dr. Jame Abraham

Breast Oncology · Cleveland Clinic

View

Dr. Azka Ali

Breast Oncology · Cleveland Clinic Lerner

View

Dr. Amy Comander

Breast Oncology · PHS

View

Dr. Paolo Tarantino

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Anastasia Martynova

Breast Oncology · USC

View

Dr. Rani Bansal

Breast Oncology · Duke

View

Dr. Gilbert Bader

Breast Oncology · OSUMC

View

Dr. VK Gadi

Breast Oncology · UI Health

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    HR
    Leading Voice

    Dr. Hope Rugo

    Hematology & Oncology · Breast Oncology
    City Of Hope National Medical Center
    hope

    Research

    Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting

    2026

    Via JAMA Ophthalmology

    Research

    Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-Mutant Metastatic Breast Cancer

    2026

    Via Clinical Cancer Research

    Research

    Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive/HER2-negative breast cancer

    2026

    Via ESMO Open

    Research

    Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer

    2026

    Via ESMO Open

    Research

    The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and control

    2026

    Via Ecancermedicalscience

    Research

    Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer

    2026

    Via ESMO Open

    Research

    KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer

    2026

    Via Clinical Cancer Research

    Research

    Clinically Meaningful, Patient-Centered Endpoints for Real-World Evidence Generation in Breast Cancer

    2026

    Via Advances in Therapy

    Research

    Detection of actionable mutations in the cerebrospinal fluid and concordance/discordance with extracranial disease in patients with breast cancer brain metastases

    2026

    Via Therapeutic Advances in Medical Oncology

    Research

    Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from clinical trials

    2026

    Via ESMO Open

    Research

    OPERA: a phase II study of DHP107 (oral paclitaxel) versus intravenous paclitaxel in patients with metastatic breast cancer

    2026

    Via Breast Cancer Research and Treatment

    Research

    Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2- breast cancer

    2026

    Via Breast (Edinburgh, Scotland)

    Research

    Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- breast cancer

    2026

    Via Breast (Edinburgh, Scotland)

    Research

    Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer

    2025

    Via NPJ Breast Cancer

    Research

    Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors

    2025

    Via Nature Communications